Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 2003

View Archived Issues

Clinical benefits of efalizumab in plaque-type psoriasis

Good efficacy and safety profile reported for arzoxifene in hormone-sensitive breast cancer

New NK1 antagonists identified by Kyorin researchers

Novartis presents new PTP1B inhibitors in a recent patent

Spanish researchers prepare and test novel cannabinoid CB1 antagonists

Sumitomo claims TGF-beta antagonists with potential in fibrotic disorders

New EGFR inhibitors discovered at Boehringer Ingelheim

Ono claims novel prostanoid DP antagonists, their preparation and use

Pfizer scientists describe novel PPARgamma ligands and their use

Phase I trial begins for ChimeriVax-West Nile vaccine

Gene expression profiling for classifying pediatric ALL

Candidate gene for obesity located by international research team

Parkinson's disease: important genetic findings and RNAi-based drug development

Final results for phase II study of R-1549 in gastric cancer

Positive long-term data obtained for Aryplase

Rat study results for injectable sustained-release ZT-1 for Alzheimer's disease

Green light for phase I/II study of Enzo's gene vector for HIV

Guilford announces positive phase II results for Aquavan

Completion of first clinical study of Durect's postoperative pain depot product

Edaravone has beneficial effects in LPS-induced liver damage

Sativex marketing agreement extended to Canada

Shire and Noven work towards MethyPatch approval

Xcytrin evaluated in combination with Rituxan and Zevalin

Intranasal QR-435 prevents influenza infection in ferrets

Spotlight on systemic lupus erythematosus

Neuroprotective efficacy of neurosteroid in spinal cord ischemia

VP-025 prevents LPS-induced LTP impairment in rat brain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...